Rabies Prevention Protocol Technical Note

This document describes the preventive measures for rabies, including rabies vaccine, rabies serum and rabies immunoglobulin.


Rabies Prevention Protocol Technical Note - cover page
Category
Other
Document type
Other
Language
Portuguese
Pages
13
File format
PDF
File size
2.9 MB
Published
18 November, 2023
Updated
18 November, 2023
MD5 checksum
2C252A24CB30E4B01DBB07B06AF626B0

About this manual

This document is a technical note issued by the Ceará Health Secretariat in Brazil, dated March 22, 2022. It provides updated guidelines for the rabies prevention protocol for humans, covering pre-exposure, post-exposure, and re-exposure scenarios. The text details changes to vaccination schedules, specifically the introduction of an intradermal route and adjusted dosing intervals, as well as guidelines for the use of antirabies serum (SAR) and human antirabies immunoglobulin (IGHAR). This manual is written in Portuguese.

What's inside

  • Apresentação
  • Atualizações no Protocolo
  • Vacina Contra Raiva Humana
  • Soro e Imunoglobulina
  • Orientações quanto à Utilização
  • Esquema de Profilaxia Pré-Exposição
  • Esquema de Profilaxia Pós-Exposição
  • Esquema de Profilaxia Reexposição

Frequently asked questions

What are the updated vaccination days for the intradermal pre-exposure protocol?

The updated protocol for intradermal pre-exposure vaccination consists of two doses on days 0 and 7.

When should antirabies serum or immunoglobulin be administered after exposure?

They should be administered as soon as possible, or at the latest within 7 days after the first dose of the rabies vaccine.

What is the recommended vaccination schedule for post-exposure prophylaxis via the intradermal route?

The intradermal post-exposure schedule involves four doses administered on days 0, 3, 7, and 14.

Download PDF (2.9 MB)

Also Manuals